Evaluating laser photobiomodulation for chemotherapy-induced peripheral neuropathy: a randomised phase II trial

PURPOSE: This study aims to evaluate the efficacy and safety of laser photobiomodulation (PBM) for treatment of established chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors. METHODS: We conducted a randomised phase II, non-comparative, sham-controlled, single-blinded clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Christina, Egger, Sam, Blinman, Prunella L., Vardy, Janette L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758032/
https://www.ncbi.nlm.nih.gov/pubmed/36526802
http://dx.doi.org/10.1007/s00520-022-07463-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758032/
https://www.ncbi.nlm.nih.gov/pubmed/36526802
http://dx.doi.org/10.1007/s00520-022-07463-y

Ejemplares similares